Fiboflapon sodium is primarily used in the field of medical research and pharmaceutical development. It is studied for its potential role as a leukotriene biosynthesis inhibitor, which makes it relevant in investigating treatments for inflammatory conditions such as asthma, arthritis, and other immune-related disorders. Researchers explore its ability to modulate the inflammatory response by targeting specific pathways involved in the production of leukotrienes, which are key mediators of inflammation. Additionally, it has been examined in preclinical studies for its potential therapeutic effects in cardiovascular diseases due to its anti-inflammatory properties. Its application remains largely experimental, focusing on understanding its mechanisms and efficacy in various disease models.